Get the Stockscreener App
19.80
2.11%
0.41
Adma Biologics Inc stock is traded at $19.80, with a volume of 2.63M.
It is up +2.11% in the last 24 hours and up +36.36% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
See More
Previous Close:
$19.39
Open:
$19.31
24h Volume:
2.63M
Relative Volume:
0.76
Market Cap:
$4.71B
Revenue:
$474.17M
Net Income/Loss:
$208.93M
P/E Ratio:
23.31
EPS:
0.8493
Net Cash Flow:
$65.61M
1W Performance:
+2.86%
1M Performance:
+36.36%
6M Performance:
-5.13%
1Y Performance:
+4.16%
1-Day Range:
$19.15
$19.87
1-Week Range:
$19.13
$20.22
52-Week Range:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
19.80 | 4.61B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.01 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
692.58 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
415.21 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.41 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.17 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
WINTON GROUP Ltd Has $4.97 Million Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
Is ADMA Biologics Inc a good long term investmentLong-Term Growth Stocks & You’ve Never Seen Stock Picks Like These - earlytimes.in
What analysts say about ProShares Trust ProShares Ultra Financials stockHigh Yield Income Stocks & Small Investment Capital Gains - earlytimes.in
Adma Biologics (ADMA) Up 43.3% Since Last Earnings Report: Can It Continue? - sharewise.com
Stonepine Capital Management LLC Sells 60,000 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Stocks With Rising Relative Strength: ADMA Biologics - Investor's Business Daily
Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - MSN
Technical Reactions to ADMA Trends in Macro Strategies - news.stocktradersdaily.com
Rhumbline Advisers Buys 30,391 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Looks Just Right With A 25% Price Jump - simplywall.st
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - sharewise.com
Legal & General Group Plc Acquires 37,699 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Northwest & Ethical Investments L.P. Has $425,000 Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Elo Mutual Pension Insurance Co Buys 25,267 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Published on: 2025-11-29 10:13:00 - moha.gov.vn
What analysts say about ADMA Biologics Inc stockMarket Sentiment Report & No Fee. No Catch. Just Smart Investment Ideas - earlytimes.in
Ensign Peak Advisors Inc Acquires 80,462 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Guidance Update: How ADMA Biologics Inc. stock valuations compare to rivals2025 AllTime Highs & Fast Gain Swing Alerts - moha.gov.vn
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 60.24%: Read This Before Placing a Bet - Zacks Investment Research
ADMA Biologics (ADMA): Assessing Valuation as Short Interest Declines and Market Sentiment Improves - Sahm
Where Will Sharp Investments Limited Stock Be in YEAR5 Growth ForecastExit Strategy Tips & These Stocks Are Just Getting Started - earlytimes.in
Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average - sharewise.com
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - sharewise.com
Adma Biologics (ADMA) Upgraded to Buy: Here's What You Should Know - sharewise.com
What's Driving the Market Sentiment Around ADMA Biologics Inc? - Benzinga
High Growth Tech Stocks In The US For November 2025 - Yahoo Finance
Arihant Foundations Housing Limited Testing Reversal Zone on Weekly ChartLong-Term Growth Stocks & Breakout Stock Alerts - earlytimes.in
Adma Biologics (ADMA) CEO Grossman sells $336k in shares By Investing.com - Investing.com South Africa
ADMA Biologics CEO Adam S Grossman Sells Shares - TradingView
[Form 4] ADMA BIOLOGICS, INC. Insider Trading Activity - Stock Titan
Adma Biologics (ADMA) CEO Grossman sells $336k in shares - Investing.com
CEO Grossman Sells 21,000 ($336K) Of Adma Biologics Inc [ADMA] - TradingView
Trading the Move, Not the Narrative: (ADMA) Edition - news.stocktradersdaily.com
ADMA Biologics: Why The Dip To $16 Resets The Buy Case (NASDAQ:ADMA) - Seeking Alpha
Why ADMA Biologics Inc. stock appeals to analysts2025 Price Targets & Risk Controlled Daily Plans - newser.com
Building trade automation scripts for ADMA Biologics Inc.Earnings Growth Summary & Daily Technical Forecast Reports - newser.com
ADMA Biologics Inc (ADMA) Stock forecasts - Yahoo Finance UK
ADMA Biologics (ADMA) Is Up 7.2% After Raised Guidance and Share Buybacks Has the Bull Case Changed? - Sahm
Will ADMA Biologics Inc. stock continue dividend increases2025 Trading Volume Trends & Stock Timing and Entry Methods - newser.com
Can ADMA Biologics Inc. stock attract ESG capital inflows2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com
Applying Wyckoff theory to ADMA Biologics Inc. stock2025 Performance Recap & Stepwise Trade Execution Plans - newser.com
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - sharewise.com
Risk adjusted return profile for ADMA Biologics Inc. analyzedJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
ADMA Biologics, Inc. (ADMA) Stock Price Quote Today & Current Price Chart - Capital.com
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for Investors - sharewise.com
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):